BTSG vs LH
BrightSpring Health Services, Inc. and Labcorp Holdings Inc., side by side — 4 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BTSG | LH |
|---|---|---|
| Revenue | $12.9B | $14.0B |
| Net income | $190.7M | $876.5M |
| Gross margin | 11.8% | 28.8% |
| Net margin | 1.5% | 6.3% |
| Return on equity | 10.8% | 10.5% |
| Diluted EPS | $0.87 | $10.46 |
| Dividend / share | — | $2.88 |
| Payout ratio | — | 27.5% |
| Free cash flow | $394.7M | $1.2B |
| Equity | $1.9B | $8.6B |
| Net debt / equity | 1.29× | 0.59× |
| Current ratio | 1.57× | 1.42× |
| Revenue CAGR 5y | — | −0.0% |
| Profit CAGR 5y | — | −10.8% |
BTSG and LH book revenue within 15% of each other, and LH keeps more of each dollar of revenue as profit (6.3% against 1.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
4 years side by side
| Fiscal year | BTSG | LH |
|---|---|---|
| FY2025 | $12.9B | $14.0B |
| FY2024 | $10.1B | $13.0B |
| FY2023 | $7.7B | $12.2B |
| FY2022 | $7.7B | $11.9B |
Net income by year
Bottom line
| Fiscal year | BTSG | LH |
|---|---|---|
| FY2025 | $190.7M | $876.5M |
| FY2024 | $-18.1M | $746.0M |
| FY2023 | $-154.6M | $418.0M |
| FY2022 | $-53.9M | $1.3B |
Advertisement
AdSense · Rectangle 336×280